Inventor · disambiguated record
Richard Pastor
Also filed as: PASTOR RICHARD · PASTOR RICHARD M
23 granted patents·24 pending applications·100 citations·filing 2000–2024
93Inventor score
Top patents by PatentIndex Score
47 records- 0192US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 0289US6472393B1Serine protease inhibitorsGENENTECH INC·Filed 2000·Granted Oct 29, 2002·37 cites·19 claims
- 0387US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0487US8637526B2Pyrazolopyrimidine JAK inhibitor compounds and methodsBLANEY JEFFREY·Filed 2011·Granted Jan 28, 2014·17 cites·18 claims
- 0585US2024150364A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 0683US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 0782US8609687B2Triazolopyridine JAK inhibitor compounds and methodsZHU BING-YAN·Filed 2012·Granted Dec 17, 2013·7 cites·45 claims
- 0880US10800780B2TDO2 InhibitorsGENENTECH INC·Filed 2016·Granted Oct 13, 2020·4 cites·17 claims
- 0977US2022389020A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1076US11603373B2TDO2 and IDO1 inhibitorsGENENTECH INC·Filed 2018·Granted Mar 14, 2023·2 cites·17 claims
- 1176US6410733B1Amidine inhibitors of serine proteasesGENENTECH INC·Filed 2001·Granted Jun 25, 2002·8 cites·20 claims
- 1275US2025115618A1Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2024·Application pending·0 cites
- 1374US8008287B2Integrase inhibitorsGILEAD SCIENCES INC·Filed 2007·Granted Aug 30, 2011·2 cites·52 claims
- 1472US11827639B2TDO2 and IDO1 inhibitorsGENENTECH INC·Filed 2018·Granted Nov 28, 2023·1 cites·14 claims
- 1571US2020002345A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2019·Application pending·0 cites
- 1670US2024132507A1TDO2 and IDO1 InhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1769US9434732B2Triazolopyridine JAK inhibitor compounds and methodsGENENTECH INC·Filed 2013·Granted Sep 6, 2016·1 cites·46 claims
- 1864US2017283424A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2017·Application pending·0 cites
- 1962US2010048557A1Triazolopyridine JAK Inhibitor Compounds and MethodsZHU BING-YAN·Filed 2009·Application pending·0 cites
- 2062US2010035875A1Triazolopyridine jak inhibitor compounds and methodsZHU BING-YAN·Filed 2009·Application pending·0 cites
- 2161US12234245B2Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·19 claims
- 2260US2024336625A1Sulfonimidamde compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 2360US2023159555A1Sulfonimidamide compounds as nlrp3 modulatorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2458US2007037813A1Serine Protease InhibitorsGENENTECH INC·Filed 2006·Application pending·0 cites
- 2558US2014378449A1Triazolopyridine jak inhibitor compounds and methodsGENENTECH INC·Filed 2014·Application pending·0 cites
- 2657US2014107099A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2013·Application pending·0 cites
- 2756US8889673B2Triazolopyridine JAK inhibitor compounds and methodsZHU BING-YAN·Filed 2012·Granted Nov 18, 2014·0 cites·6 claims
- 2855US12358951B2Cyclic peptide antibioticsGENENTECH INC·Filed 2021·Granted Jul 15, 2025·0 cites·22 claims
- 2955US2017333406A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3054US11560391B2Sulfonylurea compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Jan 24, 2023·0 cites·21 claims
- 3154US2008076740A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 3254US2005186198A1Serine protease inhibitorsGENENTECH INC·Filed 2005·Application pending·0 cites
- 3354US2015152117A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 3452US6919369B2Serine protease inhibitorsGENENTECH INC·Filed 2002·Granted Jul 19, 2005·0 cites·17 claims
- 3552US2016333011A1Triazolopyridine jak inhibitor compounds and methodsGENENTECH INC·Filed 2016·Application pending·0 cites
- 3650US2016244456A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2016·Application pending·0 cites
- 3748US6838479B2Amidine inhibitors of serine proteasesGENENTECH INC·Filed 2001·Granted Jan 4, 2005·0 cites·9 claims
- 3848US2016024089A1Triazolopyridine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 3947US11279735B2Cyclic peptide antibioticsGENENTECH INC·Filed 2020·Granted Mar 22, 2022·0 cites·28 claims
- 4047US10358437B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jul 23, 2019·0 cites·9 claims
- 4144US2014309210A1Indazole compounds, compositions and methods of use thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 4244US2008076738A1Phosphonate Analogs Of Hiv Integrase Inhibitor CompoundsCAI ZHENHONG R·Filed 2005·Application pending·0 cites
- 4344US2006116356A1Phosphonate analogs of HIV integrase inhibitor compoundsCAI ZHENHONG R·Filed 2005·Application pending·0 cites
- 4441US2007072831A1Integrase inhibitor compoundsGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 4540US10280149B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted May 7, 2019·0 cites·21 claims
- 4638US10155764B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Dec 18, 2018·0 cites·23 claims
- 4727US9573899B2USP7 inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Feb 21, 2017·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Richard Pastor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →